The National Institute on Aging and Alzheimer's Association (NIA-AA) has classified or staged AD according to the presence of amyloid (A), tau pathology (T) and neurodegeneration (N) giving rise to the ATN framework [4]. The gene discussed is MAPT; the disease is Alzheimer disease.